Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis
- 1 November 2015
- journal article
- research article
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 3 (11) , 886-894
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Negative appraisals of insulin therapy are common among adults with Type 2 diabetes using insulin: Results from Diabetes MILES – Australia cross‐sectional surveyDiabetic Medicine, 2015
- Trends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010Annals of Internal Medicine, 2014
- Handling of Rescue and Missing Data Affects Synthesis and Interpretation of Evidence: The Sodium–Glucose Cotransporter 2 Inhibitor ExampleAnnals of Internal Medicine, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trialThe Lancet, 2010
- Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulinDiabetes, Obesity and Metabolism, 2009
- Meta-Analysis: Efficacy and Safety of Inhaled Insulin Therapy in Adults with Diabetes MellitusAnnals of Internal Medicine, 2006
- Pulmonary insulin delivery by means of the Technosphere™ drug carrier mechanismExpert Opinion on Drug Delivery, 2005
- Resistance to Insulin Therapy Among Patients and ProvidersDiabetes Care, 2005
- Tests of Glycemia in DiabetesDiabetes Care, 2004